2016
DOI: 10.3389/fbioe.2016.00082
|View full text |Cite
|
Sign up to set email alerts
|

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing

Abstract: Wound healing is an intricate process that requires complex coordination between many cell types and an appropriate extracellular microenvironment. Chronic wounds often suffer from high protease activity, persistent infection, excess inflammation, and hypoxia. While there has been intense investigation to find new methods to improve cutaneous wound care, the management of chronic wounds, burns, and skin wound infection remain challenging clinical problems. Ideally, advanced wound dressings can provide enhanced… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
170
0
3

Year Published

2017
2017
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 226 publications
(174 citation statements)
references
References 197 publications
1
170
0
3
Order By: Relevance
“…Additionally, growth factor levels including the epidermal growth factor (EGF), basic fibroblast growth factor (FGF‐2), transforming growth factor‐β (TGF‐β), platelet‐derived growth factor (PDGF), and vascular endothelial growth factor (VEGF) are decreased in chronic wounds compared to normal healing acute wounds . Thus, the implementation of growth factors into topical wound dressings or biomaterials represents a promising approach to treat chronic wounds byrestoring the natural physiological wound healing cascade …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, growth factor levels including the epidermal growth factor (EGF), basic fibroblast growth factor (FGF‐2), transforming growth factor‐β (TGF‐β), platelet‐derived growth factor (PDGF), and vascular endothelial growth factor (VEGF) are decreased in chronic wounds compared to normal healing acute wounds . Thus, the implementation of growth factors into topical wound dressings or biomaterials represents a promising approach to treat chronic wounds byrestoring the natural physiological wound healing cascade …”
Section: Introductionmentioning
confidence: 99%
“…16 Thus, the implementation of growth factors into topical wound dressings or biomaterials represents a promising approach to treat chronic wounds by restoring the natural physiological wound healing cascade. [17][18][19] One initial study modified silk mats with EGF by mixing the growth factor into a silk fibroin solution during electrospinning. Those biofunctionalized silk mats exhibited a slow release rate of EGF for 170 h and were able to promote wound healing by accelerating the wound closure of wounded human skin-equivalents in vitro.…”
Section: Introductionmentioning
confidence: 99%
“…In order to mimic the extracellular matrix (ECM) conditions of the wound and to provide a scaffold for the fibroblasts for collagen deposition, ECM-based therapies have gained popularity [38]. A phase I clinical trial using fibroin to enhance wound healing is currently underway.…”
Section: Discussionmentioning
confidence: 99%
“…However, further investigations are required to guarantee that the activity of antimicrobials improves efficiency, in combination with other therapies, against the diverse microorganism populations found in DFU infections. Table 9 displays the current treatments for DFUs (drugs, devices, and biologics) that are FDA-approved [151,152]. Table 9.…”
Section: Collateral Effects Of Antimicrobials In Different Dfu Therapiesmentioning
confidence: 99%